Affinity Asset Advisors, LLC
CIK 1773195 · Holdings on Mar 31, 2024 · First reported May 14, 2024
Top ten holdings
Q1 2024- APGE6.40%
- XENE5.86%
- MDGL4.99%
- CRNX3.58%
- AUTL3.50%
- CLDX3.48%
- ACLX3.39%
- VERA3.29%
- 45790W1083.29%
- TEVAN3.21%
Share classes counted separately40.99%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- 15678U128Weight decreased · -4.28 pp6.34% → 2.06%Shares -450.00K (-60.00%)
- APGEWeight increased · +3.41 pp2.99% → 6.40%Shares +55.00K (+10.24%)
- KURAWeight increased · +1.98 pp0.55% → 2.53%Shares +538.96K (+281.39%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | APGEAPOGEE THERAPEUTICS INC View history and evidence | $39.34M | 6.40% | 592.09K shares | 2.99% → 6.40%+3.41 pp +55.00K (+10.24%) | Added | ↗▾ |
| 02 | XENEXENON PHARMACEUTICALS INC View history and evidence | $36.05M | 5.86% | 837.39K shares | 4.22% → 5.86%+1.64 pp +377.39K (+82.04%) | Added | ↗▾ |
| 03 | MDGLMADRIGAL PHARMACEUTICALS INC View history and evidence | $30.71M | 4.99% | 115.00K shares | 4.61% → 4.99%+0.38 pp +15.00K (+15.00%) | Added | ↗▾ |
| 04 | CRNXCRINETICS PHARMACEUTICALS IN View history and evidence | $22.00M | 3.58% | 470.00K shares | 3.17% → 3.58%+0.41 pp +22.91K (+5.12%) | Added | ↗▾ |
| 05 | AUTLAUTOLUS THERAPEUTICS PLCSPON ADS View history and evidence | $21.53M | 3.50% | 3.38M shares | 1.99% → 3.50%+1.51 pp +1.82M (+117.68%) | Added | ↗▾ |
| 06 | CLDXCELLDEX THERAPEUTICS INCCOM NEW View history and evidence | $21.40M | 3.48% | 510.00K shares | 3.16% → 3.48%+0.32 pp +110.00K (+27.50%) | Added | ↗▾ |
| 07 | ACLXARCELLX INCCOMMON STOCK View history and evidence | $20.86M | 3.39% | 300.00K shares | 3.76% → 3.39%-0.37 pp -40.00K (-11.76%) | Reduced | ↗▾ |
| 08 | VERAVERA THERAPEUTICS INCCL A View history and evidence | $20.27M | 3.29% | 470.00K shares | Prior unavailable +470.00K | New | ↗▾ |
| 09 | 45790W108INOZYME PHARMA INC View history and evidence | $20.24M | 3.29% | 2.64M shares | 1.60% → 3.29%+1.69 pp +756.72K (+40.13%) | Added | ↗▾ |
| 10 | TEVANTEVA PHARMACEUTICAL-SP ADRSPONSORED ADS View history and evidence | $19.75M | 3.21% | 1.40M shares | 3.95% → 3.21%-0.74 pp -500.00K (-26.32%) | Reduced | ↗▾ |
Options overlay 18
$192.69M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
XBISS SPDR S&P BIOTECH ETFS&P BIOTECH View history and evidence | Put | 700.00K | $66.42M | +700.00K | ▾ |
MRNAMODERNA INC View history and evidence | Put | 400.00K | $42.62M | +400.00K | ▾ |
TEVANTEVA PHARMACEUTICAL-SP ADRSPONSORED ADS View history and evidence | Call | 1.66M | $23.35M | +255.00K (+18.21%) | ▾ |
3 / 18 options · preview only
Exited positions 27
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| IMGN IMMUNOGEN INC | Non-derivative | -1,404,608 | -$41.65M | SEC filing ↗ | SEC filing ↗ |
| CBAY CYMABAY THERAPEUTICS INC | Non-derivative | -1,090,441 | -$25.76M | SEC filing ↗ | SEC filing ↗ |
| LIANY LIANBIO-ADR | Non-derivative | -3,779,694 | -$16.90M | SEC filing ↗ | SEC filing ↗ |
3 / 27 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1773195 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-05-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 807766692
}Research all 95 reported holdings.
This page includes 30 of 95 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 95 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1773195","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1773195","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.